Hanmi Pharm. Co., Ltd.
128940
Rank in Stocks
#4358
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Share Price
$279.16
Market Cap
$3.54B
Change (1 day)
-2.37%
Change (1 year)
14.50%
Country
KR
Trade Hanmi Pharm. Co., Ltd. (128940)
Category
Healthcare
P/S ratio for Hanmi Pharm. Co., Ltd. (128940)
P/S ratio as of October 2026 TTM: 2.84
According to Hanmi Pharm. Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.84. At the end of 2024 the company had a P/S ratio of 2.38.
P/S ratio history for Hanmi Pharm. Co., Ltd. from 2010 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 2.84 | -24.07% |
| 2025 | 3.74 | 57.32% |
| 2024 | 2.38 | -21.95% |
| 2023 | 3.05 | 9.33% |
| 2022 | 2.79 | -0.60% |
| 2021 | 2.80 | -31.39% |
| 2020 | 4.09 | 27.84% |
| 2019 | 3.20 | -36.24% |
| 2018 | 5.01 | -28.17% |
| 2017 | 6.98 | 112.34% |
| 2016 | 3.29 | -41.73% |
| 2015 | 5.64 | 315.34% |
| 2014 | 1.36 | -1.19% |
| 2013 | 1.37 | -5.57% |
| 2012 | 1.46 | 82.83% |
| 2011 | 0.80 | -56.85% |
| 2010 | 1.85 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 2.82 | -0.85% |
DE
|
|
| 3.02 | 6.26% |
DE
|
|
| 2.19 | -23.00% |
JP
|
|
| 8.92 | 214.12% |
CH
|
|
| 7.04 | 147.92% |
IN
|
